Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

Article  PubMed  Google Scholar 

Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N et al (2013) Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol 24:1459–1466

Article  CAS  PubMed  Google Scholar 

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA (2014) Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 65:20–25

Article  PubMed  Google Scholar 

Abdollah F, Karnes RJ, Suardi N, Cozzarini C, Gandaglia G, Fossati N et al (2014) Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. J Clin Oncol 32:3939–3947

Article  PubMed  Google Scholar 

Abdollah F, Karnes RJ, Suardi N, Cozzarini C, Gandaglia G, Fossati N et al (2014) Predicting survival of patients with node-positive prostate cancer following multimodal treatment. Eur Urol 65:554–562

Article  PubMed  Google Scholar 

Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG et al (2016) Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol 70:926–937

Article  PubMed  Google Scholar 

Hovels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395

Article  CAS  PubMed  Google Scholar 

Preisser F, van den Bergh RCN, Gandaglia G, Ost P, Surcel CI, Sooriakumaran P et al (2020) Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D’Amico intermediate and high risk prostate cancer treated with radical prostatectomy: a multi-institutional study. J Urol 203:338–343

Article  PubMed  Google Scholar 

Fossati N, Willemse PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E et al (2017) The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 72:84–109

Article  PubMed  Google Scholar 

Hueting TA, Cornel EB, Somford DM, Jansen H, van Basten JA, Pleijhuis RG et al (2018) External validation of models predicting the probability of lymph node involvement in prostate cancer patients. Eur Urol Oncol 1:411–417

Article  PubMed  Google Scholar 

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480–487

Article  PubMed  Google Scholar 

Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell’Oglio P, Bravi CA et al (2017) Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer. Eur Urol 72:632–640

Article  PubMed  Google Scholar 

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N et al (2019) A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur Urol 75:506–514

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

Article  CAS  PubMed  Google Scholar 

D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974

Article  CAS  PubMed  Google Scholar 

Van Leenders G, Van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF et al (2020) The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol 44:e87–e99

Article  PubMed  PubMed Central  Google Scholar 

Tamhankar AS, Patil SR, Ahluwalia P, Gautam G (2018) Does continuation of low-dose aspirin during robot-assisted radical prostatectomy compromise surgical outcomes? J Endourol 32:852–858

Article  PubMed  Google Scholar 

Batra V, Gautam G, Jaipuria J, Suryavanshi M, Khera R, Ahlawat R (2015) Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy. Indian J Urol 31:217–222

Article  PubMed  PubMed Central  Google Scholar 

Carbin DD, Tamhankar AS, Ahluwalia P, Gautam G (2022) Robot-assisted radical prostatectomy in indian men of age 75 years and above: a propensity scorematched analysis. J Robot Surg 16(4):799–806. https://doi.org/10.1007/s11701-021-01301-9

Article  PubMed  Google Scholar 

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

Article  PubMed  PubMed Central  Google Scholar 

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–29

Article  PubMed  Google Scholar 

Stata statistical software: release 12.0. College Station, TX: StataCorp LP; 2011

Sahin A, Urkmez A, Yildirim C, Ali Kutluhan M, Topaktas R, Verit A (2020) Sensitivity and specificity of Briganti nomogram in Turkish patients undergoing radical prostatectomy and pelvic lymph node dissection. Aging Male 23:836–840

Article  PubMed  Google Scholar 

Venclovas Z, Muilwijk T, Matjosaitis AJ, Jievaltas M, Joniau S, Milonas D (2021) Head-to-head comparison of two nomograms predicting probability of lymph node invasion in prostate cancer and the therapeutic impact of higher nomogram threshold. J Clin Med 10(5):999. https://doi.org/10.3390/jcm10050999

Article  PubMed  PubMed Central  Google Scholar 

Nason GJ, O’Connor EM, MacMahon D, Moss B, Considine SW, Cahill A et al (2018) Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer. Ir J Med Sci 187:33–37

Article  CAS  PubMed  Google Scholar 

Hansen J, Rink M, Bianchi M, Kluth LA, Tian Z, Ahyai SA et al (2013) External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. Prostate 73:211–218

Article  PubMed  Google Scholar 

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79:243–62

Article  CAS  PubMed  Google Scholar 

Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T et al (2019) Prostate cancer, Version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17:479–505

Article  CAS  PubMed  Google Scholar